D'Orazio & Associates’s ResMed RMD Stock Holding History

D'Orazio & Associates’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-112	Closed	-$30K	–	573
2021 Q3	$30K	Buy	+112	New	+$30.6K	0.01%	293

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

D'Orazio & Associates's RMD Position: Q4 2021 in Review

D'Orazio & Associates sold out of ResMed (RMD) in Q4 2021, closing a stake of 112 shares — an estimated $30K sold.

D'Orazio & Associates first reported a position in RMD in Q3 2021 and held it in 1 quarter. The position peaked at $30K in Q3 2021. 723 funds tracked by Wall St. Rank hold RMD as of Q4 2021.

D'Orazio & Associates reported no remaining ResMed position as of Q4 2021 after selling out during the quarter.
D'Orazio & Associates sold 112 ResMed shares in Q4 2021, an estimated $30K.
D'Orazio & Associates first reported a position in ResMed in Q3 2021 and held it in 1 quarter.
D'Orazio & Associates's ResMed position peaked at $30K in Q3 2021.
723 funds tracked by Wall St. Rank held ResMed as of Q4 2021.

Based on D'Orazio & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.